| Application number | Title of the application | Filing Date | Status |
|---|
| 10/030549 | Human g-protein coupled receptor | Jan 10, 2002 | Abandoned |
Array
(
[id] => 6536169
[patent_doc_number] => 20020193301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'TGF-alpha polypeptides, functional fragments and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 10/039119
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22961
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10039119
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/039119 | TGF-alpha polypeptides, functional fragments and methods of use therefor | Jan 3, 2002 | Abandoned |
| 10/018483 | Head trauma induced cytoplasmatic calcium binding protein | Dec 18, 2001 | Abandoned |
Array
(
[id] => 5788300
[patent_doc_number] => 20020160941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Treating compositions with lactoferrin'
[patent_app_type] => new
[patent_app_number] => 10/023096
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9332
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160941.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023096
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023096 | Treating compositions with lactoferrin | Dec 17, 2001 | Abandoned |
Array
(
[id] => 6668912
[patent_doc_number] => 20030113896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Purified antigen for Alzheimer\'s disease and methods of obtaining and using same'
[patent_app_type] => new
[patent_app_number] => 10/017822
[patent_app_country] => US
[patent_app_date] => 2001-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14550
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10017822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/017822 | Purified antigen for Alzheimer's disease and methods of obtaining and using same | Dec 11, 2001 | Issued |
Array
(
[id] => 1082739
[patent_doc_number] => 06833237
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-21
[patent_title] => 'Genes involved in stroke response and/or regulated by FK506, proteins encoded thereby, and methods of use'
[patent_app_type] => B1
[patent_app_number] => 10/021338
[patent_app_country] => US
[patent_app_date] => 2001-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 39300
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/833/06833237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021338
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021338 | Genes involved in stroke response and/or regulated by FK506, proteins encoded thereby, and methods of use | Dec 11, 2001 | Issued |
Array
(
[id] => 6774141
[patent_doc_number] => 20030017479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Methods for the detection, treatment, and prevention of neurodegeneration'
[patent_app_type] => new
[patent_app_number] => 10/014079
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10048
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017479.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014079 | Methods for the detection, treatment, and prevention of neurodegeneration | Dec 10, 2001 | Abandoned |
Array
(
[id] => 190917
[patent_doc_number] => 07642228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-05
[patent_title] => 'Method for making heteromultimeric polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/010245
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 21742
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/642/07642228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10010245
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/010245 | Method for making heteromultimeric polypeptides | Dec 6, 2001 | Issued |
Array
(
[id] => 1098391
[patent_doc_number] => 06818215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-16
[patent_title] => 'Antibodies to senescent cell-derived inhibiters of DNA synthesis'
[patent_app_type] => B2
[patent_app_number] => 10/008960
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 50461
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/818/06818215.pdf
[firstpage_image] =>[orig_patent_app_number] => 10008960
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/008960 | Antibodies to senescent cell-derived inhibiters of DNA synthesis | Dec 6, 2001 | Issued |
Array
(
[id] => 6687929
[patent_doc_number] => 20030031654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Prohormone convertase transformed cells and polypeptide synthesis'
[patent_app_type] => new
[patent_app_number] => 09/997868
[patent_app_country] => US
[patent_app_date] => 2001-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 31181
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031654.pdf
[firstpage_image] =>[orig_patent_app_number] => 09997868
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/997868 | Prohormone convertase transformed cells and polypeptide synthesis | Nov 27, 2001 | Abandoned |
Array
(
[id] => 727976
[patent_doc_number] => 07041457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-09
[patent_title] => 'Gαq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors'
[patent_app_type] => utility
[patent_app_number] => 09/989497
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5037
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041457.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989497
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989497 | Gαq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors | Nov 20, 2001 | Issued |
| 09/959308 | Treatment of acute myocardial infarction with a substance related to the growth hormone axis | Nov 15, 2001 | Abandoned |
Array
(
[id] => 6361065
[patent_doc_number] => 20020058613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Methods of controlling axonal growth'
[patent_app_type] => new
[patent_app_number] => 10/035376
[patent_app_country] => US
[patent_app_date] => 2001-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15025
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058613.pdf
[firstpage_image] =>[orig_patent_app_number] => 10035376
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/035376 | Methods of controlling axonal growth | Oct 31, 2001 | Abandoned |
Array
(
[id] => 6438611
[patent_doc_number] => 20020128186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Antimicrobial polypeptide, nucleic acid, and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/013036
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8861
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128186.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013036 | Antimicrobial polypeptide, nucleic acid, and methods of use | Oct 29, 2001 | Issued |
Array
(
[id] => 5999783
[patent_doc_number] => 20020028473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Components of dense microspheres derived from mammalian brain tissue detectable in cerebrospinal fluid'
[patent_app_type] => new
[patent_app_number] => 09/984304
[patent_app_country] => US
[patent_app_date] => 2001-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7976
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028473.pdf
[firstpage_image] =>[orig_patent_app_number] => 09984304
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/984304 | Components of dense microspheres derived from mammalian brain tissue detectable in cerebrospinal fluid | Oct 28, 2001 | Abandoned |
Array
(
[id] => 6736015
[patent_doc_number] => 20030013650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'VR-OAC, an osomotically activated channel protein, nucleic acids encoding it, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/027828
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 39531
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013650.pdf
[firstpage_image] =>[orig_patent_app_number] => 10027828
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/027828 | VR-OAC, an osomotically activated channel protein, nucleic acids encoding it, and uses thereof | Oct 24, 2001 | Abandoned |
Array
(
[id] => 6668917
[patent_doc_number] => 20030113901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Cell production'
[patent_app_type] => new
[patent_app_number] => 10/045963
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3228
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113901.pdf
[firstpage_image] =>[orig_patent_app_number] => 10045963
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/045963 | Cell production | Oct 23, 2001 | Abandoned |
Array
(
[id] => 6613161
[patent_doc_number] => 20100310452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 10/012169
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 103
[patent_figures_cnt] => 103
[patent_no_of_words] => 30308
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310452.pdf
[firstpage_image] =>[orig_patent_app_number] => 10012169
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/012169 | PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF | Oct 23, 2001 | Abandoned |
Array
(
[id] => 773282
[patent_doc_number] => 07001763
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-21
[patent_title] => 'Human semaphorin proteins and polynucleotides encoding the same'
[patent_app_type] => utility
[patent_app_number] => 09/981318
[patent_app_country] => US
[patent_app_date] => 2001-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9307
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001763.pdf
[firstpage_image] =>[orig_patent_app_number] => 09981318
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/981318 | Human semaphorin proteins and polynucleotides encoding the same | Oct 16, 2001 | Issued |
Array
(
[id] => 1334836
[patent_doc_number] => 06596852
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-22
[patent_title] => 'Antibodies that bind the cytokine designated LERK-5'
[patent_app_type] => B2
[patent_app_number] => 09/978339
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13143
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596852.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978339
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978339 | Antibodies that bind the cytokine designated LERK-5 | Oct 14, 2001 | Issued |
